Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

13/02/2024

Feb 13, 2024 7:01 pm

Feb 13, 2024 6:59 pm

Feb 13, 2024 6:54 pm

Feb 13, 2024 6:48 pm

Feb 13, 2024 6:47 pm

Feb 13, 2024 6:38 pm

Feb 13, 2024 6:37 pm

Feb 13, 2024 6:34 pm

Feb 13, 2024 6:30 pm

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29

13/02/2024

Christine M. Lovly: Join us for the AACR “Runners (and Walkers) for Research” event on Saturday, April 6th

Douglas Flora: We are launching AI in Precision Oncology this week

Jill Feldman: It’s the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means

Yüksel Ürün: Pegfilgrastim in metastatic germ-cell tumor treatment with bleomycin shows no increased risk for lung toxicity

Global Summit on War and Cancer: Henrik Grigoryan’s speech on his personal experience as an hematologist/oncologist at the warzone

David B. Solit: >120,000 tumor/cfDNA samples analyzed

Françoise Meunier: Next Thursday, key European stakeholders will take stock of the progress made at the EU level to protect cancer survivors from financial discrimination

How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer – The ASCO Post

Ani Haykuni: I’m one of those people who likes to create their own stories, rather than just admiring other companies

Robin Zon: Had an outstanding meeting with Representative Rudy Yakam

Headlines

13/02/2024

Christine M. Lovly: Join us for the AACR “Runners (and Walkers) for Research” event on Saturday, April 6th

Douglas Flora: We are launching AI in Precision Oncology this week

Jill Feldman: It’s the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means

Yüksel Ürün: Pegfilgrastim in metastatic germ-cell tumor treatment with bleomycin shows no increased risk for lung toxicity

Global Summit on War and Cancer: Henrik Grigoryan’s speech on his personal experience as an hematologist/oncologist at the warzone

David B. Solit: >120,000 tumor/cfDNA samples analyzed

Françoise Meunier: Next Thursday, key European stakeholders will take stock of the progress made at the EU level to protect cancer survivors from financial discrimination

How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer – The ASCO Post

Ani Haykuni: I’m one of those people who likes to create their own stories, rather than just admiring other companies

Robin Zon: Had an outstanding meeting with Representative Rudy Yakam

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap